Skip to main content
. 2020 Sep 17;19(7):1469–1479.e19. doi: 10.1016/j.cgh.2020.09.027

Table 5.

Univariate and Multivariate Analyses: Risk of Severe COVID-19 (Composite Endpoint) Among Patients With Chronic Liver Disease and COVID-19

Univariate model for severe COVID-19
Multivariate model for severe COVID-19
OR (95% CI) P value OR (95% CI) P value
Demographic factors
 Age (per 10 year) 1.46 (1.32–1.62) <.001 1.43 (1.25–1.65) <.001
 Male 1.38 (1.05–1.83) .022 1.28 (0.90–1.81) .172
 Race/ethnicity
 Non-Hispanic white 1 1
 Non-Hispanic black 0.93 (0.66–1.32) .685 0.83 (0.54–1.28) .406
 Hispanic 1.47 (1.01–2.14) .045 2.33 (1.47–3.70) <.001
 Non-Hispanic Asian 1.42 (0.72–2.81) 314 1.90 (0.85–4.27) .124
 Other 2.57 (1.14–5.83) .024 3.40 (1.31–8.81) .012
Liver-related factors
 Etiology of liver disease
 HCV 1 1
 ALD 1.72 (0.94–3.15) .077 2.08 (0.97–4.45) .059
 NAFLD 0.55 (0.39–0.80) .001 0.68 (0.41–1.13) .137
 HBV 0.64 (0.35–1.15) .139 0.99 (0.46–2.13) .973
 Other 0.72 (0.40–1.30) .275 1.27 (0.60–2.70) .536
 Presence of cirrhosis
 No 1 1
 Compensated cirrhosis 1.21 (0.82–1.79) .338 0.70 (0.43–1.14) .152
 Decompensated cirrhosis 3.85 (2.13–6.95) <.001 2.50 (1.20–5.21) .015
 Presence of HCC 3.70 (1.08–12.67) .037 2.99 (0.62–14.36) .171
Comorbidities
 Diabetes 1.81 (1.36–2.41) <.001 1.51 (1.04–2.19) .029
 Hypertension 1.43 (1.08–1.89) .012 1.16 (0.80–1.68) .434
 Obesity 0.76 (0.57–1.00) .052 1.21 (0.84–1.76) .302
 Cardiovascular disease 2.51 (1.65–3.81) <.001 1.85 (1.09–3.13) .022
 COPD 2.68 (1.49–4.80) .001 2.26 (1.15–4.45) .019
Behavioral factors
 Smoking status
 No 1 1
 Past smoker 1.53 (1.11–2.10) .009 0.96 (0.65–1.43) .855
 Current smoker 1.21 (0.76–1.90) .419 1.00 (0.54–1.83) .990
 Alcohol consumption
 Do not drink currently 1 1
 Social drinking 0.53 (0.37–0.75) <.001 0.84 (0.55–1.26) .390
 Current daily drinking 1.09 (0.70–1.71) .699 0.98 (0.53–1.83) .953

NOTE. Multivariate model for all-cause mortality was adjusted for age, gender, race/ethnicity, etiology of chronic liver disease, cirrhosis, HCC, diabetes, hypertension, obesity, cardiovascular disease, COPD, smoking status, and alcohol consumption. Boldface indicates statistical significance.

ALD, alcohol-related liver disease; CI, confidence interval; COPD, chronic obstructive pulmonary disease; COVID-19, coronavirus disease 2019; HBV, hepatitis B virus infection; HCC, hepatocellular carcinoma; HCV, hepatitis C virus infection; NAFLD, nonalcoholic fatty liver disease; OR, odds ratio.